-
Loading metrics
Open Access
Peer-reviewed
Research Article
Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease
-
Daniel Bradshaw ,
Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Writing – original draft
* E-mail: daniel.bradshaw@ukhsa.gov.uk
Current address: Virus Reference Department, UK Health Security Agency, London, United Kingdom
Affiliation The Lawson Unit, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom
⨯ -
Iga Abramowicz,
Roles Data curation, Project administration, Writing – review & editing
Affiliation Brighton and Sussex Clinical Trials Unit, University of Sussex, Brighton, United Kingdom
⨯ -
Stephen Bremner,
Roles Data curation, Formal analysis, Methodology, Writing – review & editing
Affiliations Brighton and Sussex Clinical Trials Unit, University of Sussex, Brighton, United Kingdom, Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom
⨯ -
Sumita Verma,
Roles Methodology, Writing – review & editing
Affiliation Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom
⨯ -
Yvonne Gilleece,
Roles Investigation, Methodology, Writing – review & editing
Affiliation The Lawson Unit, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom
⨯ -
Sarah Kirk,
Roles Investigation
Affiliation The Lawson Unit, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom
⨯ -
Mark Nelson,
Roles Investigation
Affiliation Department of HIV and Sexual Health, Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom
⨯ -
Rosalie Housman,
Roles Investigation
Affiliation Department of HIV and Sexual Health, Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom
⨯ -
Helena Miras,
Roles Investigation
Affiliation Grahame Hayton Unit, Barts Health NHS Trust, London, United Kingdom
⨯ -
Chloe Orkin,
Roles Investigation, Writing – review & editing
Affiliation Grahame Hayton Unit, Barts Health NHS Trust, London, United Kingdom
⨯ -
Ashini Fox,
Roles Investigation
Affiliation Department of Genitourinary Medicine and HIV, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
⨯ -
Michael Curnock,
Roles Investigation
Affiliation Department of Genitourinary Medicine and HIV, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
⨯ -
Louise Jennings,
Roles Investigation
Affiliation Department of HIV, North Bristol NHS Trust, Bristol, United Kingdom
⨯ -
Mark Gompels,
Roles Investigation
Affiliation Department of HIV, North Bristol NHS Trust, Bristol, United Kingdom
⨯ -
Emily Clarke,
Roles Investigation, Writing – review & editing
Affiliation Department of Genitourinary Medicine and HIV, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom
⨯ -
Rachel Robinson,
Roles Investigation
Affiliation Department of Genitourinary Medicine and HIV, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom
⨯ -
Pauline Lambert,
Roles Investigation
Affiliation Department of Infectious Diseases, South Tees Hospitals NHS Foundation Trust, Middlesbrough, United Kingdom
⨯ -
David Chadwick,
Roles Investigation
Affiliation Department of Infectious Diseases, South Tees Hospitals NHS Foundation Trust, Middlesbrough, United Kingdom
⨯ - [ ... ],
-
Nicky Perry
Roles Investigation, Methodology, Project administration
Affiliation Brighton and Sussex Clinical Trials Unit, University of Sussex, Brighton, United Kingdom
⨯ - [ view all ]
- [ view less ]
Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease
- Daniel Bradshaw,
- Iga Abramowicz,
- Stephen Bremner,
- Sumita Verma,
- Yvonne Gilleece,
- Sarah Kirk,
- Mark Nelson,
- Rosalie Housman,
- Helena Miras,
- Chloe Orkin
- Published: July 14, 2023
- https://doi.org/10.1371/journal.pone.0288598